UCN2
Urocortin-2
Also known as: SRP, UCN-II, UCN2_HUMAN, UCNI, URP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96RP3
- Gene
- UCN2
- Ensembl
- ENSG00000145040
- Chromosome
- 3
- Canonical length
- 112 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Vesicles
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene is a member of the sauvagine/corticotropin-releasing factor/urotensin I family. It is structurally related to the corticotropin-releasing factor (CRF) gene and the encoded product is an endogenous ligand for CRF type 2 receptors. In the brain it may be responsible for the effects of stress on appetite. In spite of the gene family name similarity, the product of this gene has no sequence similarity to urotensin II. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
112 residues, UniProt reviewed canonical sequence.
>Q96RP3|UCN2
1 MTRCALLLLM VLMLGRVLVV PVTPIPTFQL RPQNSPQTTP RPAASESPSA APTWPWAAQS
61 HCSPTRHPGS RIVLSLDVPI GLLQILLEQA RARAAREQAT TNARILARVG HCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UCN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- skin: 12 nTPM
- cervix: 4.3 nTPM
- vagina: 4.1 nTPM
- esophagus: 3.2 nTPM
- prostate: 3 nTPM
- salivary gland: 1.5 nTPM
Single-cell type
- schwann cells: 5.5 nCPM
- basal keratinocytes: 3.2 nCPM
- epididymal basal cells: 1.7 nCPM
- thymic myoid cells: 1.4 nCPM
- gastric progenitor cells: 1.3 nCPM
- ocular epithelial cells: 1.2 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.9 nTPM
- hypothalamus: 0.8 nTPM
- cerebellum: 0.7 nTPM
- medulla oblongata: 0.6 nTPM
- pons: 0.6 nTPM
- midbrain: 0.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.78
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 0.19
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- cellular response to nutrient levels
- digestion
- hormone-mediated signaling pathway
Molecular functions
- corticotropin-releasing hormone receptor 2 binding
- corticotropin-releasing hormone receptor binding
- hormone activity
- hormone binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UCN2 as an antibody target. Whether an autoantibody or antibody against UCN2 could matter depends on whether native UCN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UCN2 is annotated as secreted, so native UCN2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label UCN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...